A Study to Evaluate the Drug Levels of Abatacept Converted From Drug Substance by Two Different Processes in Healthy Participants
Clinical trial NCT05981976 · COMPLETED
Trial details
- NCT number
- NCT05981976
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-18
- Primary completion
- 2023-12-14
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.